Article

Ten Diagnostic Signs of ILD, and More

Key features in the clinical examination of interstitial lung diseases and their management are the focus of a new clinical review. Highlights here.

Wallis A, Spinks K. Clinical Review: The diagnosis and management of interstitial lung diseases. BMJ 2015;350:h2072 doi: 10.1136/bmj.h2072 (7 May 2015)

Interstitial lung disease is an involvement of rheumatic disease, and an adverse effect of methotrexate, leflunamide, sulphasalazine, penicillamine, and anti-tumor necrosis factor agents.

This is a quick clinical review, emphasizing diagnosis.

Key features in the clinical examination are:

•    Bi-basal end inspiratory crepitations
•    Inspiratory squeaks
•    Finger clubbing
•    Pleural effusion
•    Pulmonary hypertension
•    Arthritis
•    Skin signs of scleroderma
•    Lymphadenopathy and hepatosplenomegaly
•    Neurological findings
•    Ocular signs

 

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.